LINC00511 and cervical carcinoma: Similarly, the silencing of LINC00511 in cervical cancer cells enhanced cancer drug paclitaxel’s sensitivity, suppressed cell viability, cell proliferation, migration and invasion, and promoted apoptosis, thereby preventing progression and recurrence [24].